PHGE — BiomX Inc.
—
NYSE ·
Health Care ·
Biotechnology ·
CIK 1739174 ·
Last close
$1.62
Market Cap
$16.38M
52W High
$8.10
52W Low
$0.36
ADV30
11,317,247
Next earnings
2026-08-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -1,296,000 | -19,140,000 | 3,251,000 | 1,168,000 | 4,132,000 |
| Sep 2025 | 0 | — | -8,536,000 | -9,166,000 | 26,168,000 | 6,923,000 | 15,682,000 |
| Jun 2025 | 0 | — | -7,433,000 | -6,037,000 | 38,050,000 | 14,046,000 | 18,890,000 |
| Mar 2025 | 0 | — | -7,756,000 | -7,659,000 | 45,654,000 | 20,116,000 | 21,155,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-28,293,000
Investing CF
$106,000
Financing CF
$11,540,000
CapEx
$-21,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-9.50
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-203,559,000
Inventory
—
Receivables
$280,000
ST Investments
—
EBIT TTM
$-38,425,000
Pretax Income TTM
$-37,366,000
Interest Exp TTM
$-1,059,000
Analysts
1
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 0 | -35,551,000 | -17,727,000 | 43,233,000 | 19,085,000 | — | -36,979,000 |
| Dec 2023 | 0 | -25,348,000 | -26,169,000 | 25,029,000 | 21,948,000 | — | -21,286,000 |
| Dec 2022 | 0 | -27,219,000 | -28,317,000 | 45,531,000 | 24,492,000 | — | -29,092,000 |
| Dec 2021 | 0 | -35,462,000 | -36,226,000 | 77,990,000 | 30,455,000 | — | -27,573,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-6.01
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| INAB | IN8BIO, INC. | $16.64M | $1.69 | — |
| PASG | Passage BIO, Inc. | $17.80M | $5.55 | — |
| ZEOX | Zeo ScientifiX, Inc. | $14.78M | $1.90 | — |
| GNTA | Genenta Science S.p.A. | $14.09M | $0.60 | — |
| CRIS | CURIS INC | $19.26M | $0.49 | — |
News headlines (Yahoo Finance, 1h cache)
BiomX’s Zorronet Puts Full AI Command-and-Control in the Palm of Your Hand
2026-05-06 20:15 · Yahoo
Zorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection Systems
2026-04-16 20:30 · Yahoo
BiomX Accelerates Defense Technology Buildout with DFSL Acquisition
2026-04-13 13:20 · Yahoo
BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications
2026-04-10 12:30 · Yahoo
BiomX Obtains Option to Acquire Control of Israeli Laser-Radar Counter-Drone System
2026-03-31 14:48 · Yahoo
BiomX Adds Former Mossad Deputy to Advisory Board
2026-03-30 13:28 · Yahoo
BiomX Inc. Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency
2026-03-27 20:30 · Yahoo
BiomX Launches Security Subsidiary in Israel and Will Initially Invest Over $3 million In Its Operations
2026-03-26 12:48 · Yahoo
Johnson & Johnson Exits 3 Biotechs but Keeps Stakes in These Rumored Acquisition Targets
2026-03-25 17:10 · Yahoo
BiomX CEO Issues Letter to Stockholders
2026-03-19 13:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.